miR-221 suppression through nanoparticle-based miRNA delivery system for hepatocellular carcinoma therapy and its diagnosis as a potential biomarker
Feng Li,1,* Feiran Wang,2,* Changlai Zhu,3 Qun Wei,1 Tianyi Zhang,1 You Lang Zhou4 1Department of Gastroenterology, 2Department of General Surgery, Affiliated Hospital of Nantong University, 3Key Laboratory of Neuroregeneration, Nantong University, 4The Hand Surgery Research Center, Department of H...
Main Authors: | Li F, Wang F, Zhu C, Wei Q, Zhang T, Zhou YL |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-04-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/mir-221-suppression-through-nanoparticle-based-mirna-delivery-system-f-peer-reviewed-article-IJN |
Similar Items
-
miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Retraction]
by: Li F, et al.
Published: (2023-04-01) -
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review
by: Maria Teresa Di Martino, et al.
Published: (2022-03-01) -
miRNA–221 and miRNA–483–3p Dysregulation in Esophageal Adenocarcinoma
by: Isotta Bozzarelli, et al.
Published: (2024-01-01) -
Assessment of miR-182, miR-221 and CEA expression in the peripheral blood of oral squamous cell carcinoma (OSCC) patients
by: Amir Rasouli, et al.
Published: (2023-08-01) -
Genistein Promotes Skeletal Muscle Regeneration by Regulating miR-221/222
by: Linyuan Shen, et al.
Published: (2022-11-01)